Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 240

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis

Open access
Plater-Zyberk, Christine, Joosten, Leo A.B., Helsen, Monique M.A., Sattonnet-Roche, Pascale, Siegfried, Christiane, Alouani, Sami, van de Loo, Fons A.J., Graber, Pierre, Aloni, Shuki, Cirillo, Rocco, Lubberts, Erik, Dinarello, Charles A., van den Berg, Wim B., Chvatchko, Yolande·2001·Journal of Clinical Investigation

Abstract

Two distinct IL-18 neutralizing strategies, i.e. a rabbit polyclonal anti-mouse IL-18 IgG and a recombinant human IL-18 binding protein (rhIL-18BP), were used to treat collagen-induced-arthritic DBA/1 mice after clinical onset of disease. The therapeutic efficacy of neutralizing endogenous IL-18 was assessed using different pathological parameters of disease progression. The clinical severity in mice undergoing collagen-induced arthritis was significantly reduced after treatment with both IL-18 neutralizing agents compared to placebo treated mice. Attenuation of the disease was associated with reduced cartilage erosion evident on histology. The decreased cartilage degradation was further documented by a significant reduction in the levels of circulating cartilage oligomeric matrix protein (an indicator of cartilage turnover). Both strategies efficiently slowed disease progression, but only anti-IL-18 IgG treatment significantly decreased an established synovitis. Serum levels of IL-6 were significantly reduced with both neutralizing strategies. In vitro, neutralizing IL-18 resulted in a significant inhibition of TNF-alpha, IL-6, and IFN-gamma secretion by macrophages. These results demonstrate that neutralizing endogenous IL-18 is therapeutically efficacious in the murine model of collagen-induced arthritis. IL-18 neutralizing antibody or rhIL-18BP could therefore represent new disease-modifying anti-rheumatic drugs that warrant testing in clinical trials in patients with rheumatoid arthritis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci12097

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 240

Metadata

Authors
Plater-Zyberk, C., Joosten, L. A. B., Helsen, M. M. A., Sattonnet-Roche, P., Siegfried, C., Alouani, S., van de Loo, F. A. J., Graber, P., Aloni, S., Cirillo, R., Lubberts, E., Dinarello, C. A., van den Berg, W. B., & Chvatchko, Y.
Venue
Journal of Clinical Investigation
Published
2001-12-15
Volume
108
Issue
12
Pages
1825-1832
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2098496304
Cited by
240
References
2
FWCI
14.08
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. https://app.cochat.ai/papers/10.1172/jci12097
The paper
Plater-Zyberk, C., Joosten, L. A. B., Helsen, M. M. A., Sattonnet-Roche, P., Siegfried, C., Alouani, S., van de Loo, F. A. J., Graber, P., Aloni, S., Cirillo, R., Lubberts, E., Dinarello, C. A., van den Berg, W. B., & Chvatchko, Y. (2001). Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. Journal of Clinical Investigation. https://doi.org/10.1172/jci12097

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.